American Century Companies’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Buy
1,830,883
+169,550
+10% +$2.29M 0.01% 1150
2026
Q1
$23M Buy
1,661,333
+309,972
+23% +$4.32M 0.01% 1119
2025
Q4
$19M Buy
1,351,361
+159,313
+13% +$2.23M 0.01% 1191
2025
Q3
$16.7M Buy
1,192,048
+144,530
+14% +$2.08M 0.01% 1222
2025
Q2
$15.7M Buy
1,047,518
+133,045
+15% +$1.9M 0.01% 1196
2025
Q1
$12.1M Buy
914,473
+52,108
+6% +$719K 0.01% 1256
2024
Q4
$13.6M Buy
862,365
+30,200
+4% +$454K 0.01% 1212
2024
Q3
$13.2M Buy
832,165
+98,050
+13% +$1.58M 0.01% 1200
2024
Q2
$11.2M Buy
734,115
+54,275
+8% +$778K 0.01% 1201
2024
Q1
$9.97M Buy
679,840
+53,540
+9% +$782K 0.01% 1206
2023
Q4
$8.72M Buy
626,300
+113,815
+22% +$1.52M 0.01% 1207
2023
Q3
$6.85M Buy
512,485
+59,650
+13% +$807K 0.01% 1215
2023
Q2
$5.72M Buy
452,835
+20,120
+5% +$235K ﹤0.01% 1254
2023
Q1
$4.87M Buy
432,715
+32,030
+8% +$346K ﹤0.01% 1273
2022
Q4
$4.15M Buy
400,685
+123,210
+44% +$1.33M ﹤0.01% 1293
2022
Q3
$2.9M Buy
277,475
+73,350
+36% +$781K ﹤0.01% 1305
2022
Q2
$2.26M Buy
204,125
+63,110
+45% +$686K ﹤0.01% 1378
2022
Q1
$1.57M Buy
141,015
+46,910
+50% +$532K ﹤0.01% 1499
2021
Q4
$1.23M Buy
94,105
+6,250
+7% +$78.8K ﹤0.01% 1568
2021
Q3
$1.15M Buy
87,855
+3,285
+4% +$43.8K ﹤0.01% 1539
2021
Q2
$1.24M Buy
84,570
+4,330
+5% +$60.6K ﹤0.01% 1451
2021
Q1
$985K Buy
80,240
+11,520
+17% +$148K ﹤0.01% 1437
2020
Q4
$980K Sell
68,720
-32,160
-32% -$433K ﹤0.01% 1273
2020
Q3
$1.4M Buy
100,880
+2,225
+2% +$26.5K ﹤0.01% 1050
2020
Q2
$1.05M Buy
98,655
+11,730
+13% +$119K ﹤0.01% 1062
2020
Q1
$701K Buy
86,925
+25,035
+40% +$209K ﹤0.01% 1082
2019
Q4
$502K Buy
+61,890
New +$489K ﹤0.01% 1182

Other funds holding RDY

American Century Companies's RDY Position: Q2 2026 in Review

American Century Companies increased its Dr. Reddy's Laboratories (RDY) stake by 10% in Q2 2026, buying an estimated $2.29M and bringing the position to 1,830,883 shares worth $26.5M. The position accounts for 0.01% of the portfolio, ranked #1150.

American Century Companies first reported a position in RDY in Q4 2019 and has held it in 27 quarters since. 226 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • American Century Companies held 1,830,883 shares of Dr. Reddy's Laboratories worth $26.5M as of Q2 2026.
  • American Century Companies bought 169,550 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $2.29M.
  • Dr. Reddy's Laboratories made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1150 holding.
  • American Century Companies first reported a position in Dr. Reddy's Laboratories in Q4 2019 and has held it in 27 quarters since.
  • 226 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.